Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer

Overview of attention for article published in OncoTargets and therapy, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy: 2 policy sources

twitter: 1 X user

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 34 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,197 followers.

@adamfeuerstein Same for breast cancer. You can compare appropriateness of same endpoints for at least BC and GBM. http://t.co/YRgySFVyHz

Reply Repost Favourite